Anti-Cyclin B2/CCNB2 antibody [X29.2]
- BOND RX™ Validated
- What is this?
4
(3 Reviews)
|
(19 Publications)
Mouse Monoclonal Cyclin B2/CCNB2 antibody. Suitable for IHC-P, Flow Cyt and reacts with Human samples. Cited in 19 publications. Immunogen corresponding to Full Length Protein corresponding to Xenopus laevis G2/mitotic-specific cyclin-B2.
View Alternative Names
G2/mitotic-specific cyclin-B2, CCNB2
- Flow Cyt
Unknown
Flow Cytometry - Anti-Cyclin B2/CCNB2 antibody [X29.2] (AB18250)
Overlay histogram showing HeLA cells stained with ab18250 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab18250, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was Mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin B2/CCNB2 antibody [X29.2] (AB18250)
IHC image of ab18250 staining in human cervical carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab18250, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 43:113782 PubMed38358892
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:9838-9858 PubMed33744866
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 134:111139 PubMed33360155
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:3025-3041 PubMed32045367
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 19:2568-2574 PubMed32194761
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 11: PubMed31717700
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 18:395-412 PubMed30730241
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 58:293-304 PubMed30334580
2018
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of cell biology 217:3901-3911 PubMed30097513
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 11:99 PubMed30068368
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com